Researchers identify potential target for cardiac fibrosis treatment

cardiac device
Credit: CC0 Public Domain

A research team led by scientists from the Consortium for Fibrosis Research & Translation (CFReT) at the University of Colorado School of Medicine has identified a potential target for treating heart failure related to fibrosis.

Fibrosis is a wound-healing response after tissue injury or stress. Cardiac can cause abnormal stiffening of the , contributing to the pathogenesis of heart failure, a condition that afflicts millions of people worldwide. Fibrosis is driven by cells called fibroblasts, which produce excess amounts of extracellular matrix proteins such as collagen, and thereby disrupt operation of the heart.

The CU-led team's study looked at an epigenetic 'reader' protein known as BRD4, showing that it serves a central role in regulating the activation of cardiac fibroblasts. They also found that chemical inhibitors of BRD4 potently block cardiac fibroblast activation, providing a foundation for developing BRD4-targeted small molecule therapies for the treatment of .

The study was published online last week and appears in the current issue of Circulation Research, the official journal of the American Heart Association and its Council on Basic Cardiovascular Sciences. The cover image for this issue of the journal was chosen from the article. The first authors are Matthew S. Stratton, Ph.D., and Rushita A. Bagchi, Ph.D., and the senior author is Timothy A. McKinsey, Ph.D.

"Our study enhances the understanding of the molecular mechanisms by which BRD4 controls pathogenic gene expression in fibroblasts," said Bagchi, who is a postdoctoral fellow in the McKinsey laboratory. "Together with forthcoming findings, this knowledge should yield a cumulative framework that guides the development of more selective BRD4 inhibitors and offers the potential to provide a therapeutic window for treatment of chronic fibrotic diseases."


Explore further

New cardiac fibrosis study identifies key proteins that translate into heart disease

More information: Matthew S. Stratton et al, Dynamic Chromatin Targeting of BRD4 Stimulates Cardiac Fibroblast Activation, Circulation Research (2019). DOI: 10.1161/CIRCRESAHA.119.315125
Journal information: Circulation Research

Citation: Researchers identify potential target for cardiac fibrosis treatment (2019, September 17) retrieved 22 October 2019 from https://medicalxpress.com/news/2019-09-potential-cardiac-fibrosis-treatment.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
3 shares

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more